Share Trading News

Key government policy dampens enthusiasm for this insurer

Key government policy dampens enthusiasm for this insurer

This FTSE 100-listed insurer is still counting the costs of the Ogden discount change, leaving analysts lukewarm on the stock, says Graeme Evans.

These are the catalysts Sirius needs to double

These are the catalysts Sirius needs to double

The fact that Sirius Minerals' project is on time and on budget is encouraging, say analysts. Graeme Evans looks at the half-year numbers.

The Oil Man: Hunting, Empyrean Energy

The Oil Man: Hunting, Empyrean Energy

Oil industry analyst Malcolm Graham-Wood has seen it all. Here, he gives Interactive Investor his opinion on the sector's top stories.

Balfour sets sight on magic 300p level as turnaround continues

Balfour sets sight on magic 300p level as turnaround continues

Balfour Beatty continues to defy construction sector troubles, posting higher profits. Graeme Evans asks whether it will breach £3 for the first time since 2014.

Two top stocks to profit from the 'lipstick effect'

What is the 'lipstick effect' and how can investors profit?

Fears of economic slowdown have prompted a return of the 'lipstick effect'. EdenTree's Phil Harris outlines stocks set to reap the rewards.

How far will Mears' stock fall?

How far will Mears' stock fall?

After Mears' profit warning Monday, chartist Alistair Strang suggests the market may have "a cunning plan" and a six-year low could be on the cards.

Is this the beginning of the end for Google's monopoly?

Is this the beginning of the end for Google's monopoly?

History has taught us that monopolies can be broken. Emil Ahmad asks whether Google's record EU fine is the end of the beginning or the beginning of the end.

The sectors that fund managers are buying

The sectors that fund managers are buying

Caution prevails in global fund portfolios, but European funds are more overweight in cyclical sectors relative to defensives, finds Graeme Evans.

Standard Life Aberdeen: Time to buy?

Standard Life Aberdeen: Time to buy?

The Standard Life Aberdeen merger has been welcomed by analysts at Barclays. Graeme Evans finds out why they've upped their target price by 49%.

Is today's India yesterday's China?

Is today's India yesterday's China?

On the 70th anniversary of Indian independence, Ed Smith at Rathbones suggests five reasons why India's potential might supersede that of China.